Star Health Q2 FY27: Underwriting Strengthens YoY, PAT Trails Street's Bar

Star Health's standalone Q2 FY27 (quarter ended September 30, 2026) print shows a business whose core insurance operations grew solidly year-on-year even as reported profit came in well short of what the Street was positioned for after Q1's beat. Standalone PAT was ₹264.81 Cr on insurance revenue of ₹5,073.77 Cr — revenue up 15.42% YoY against the Ind AS-restated year-ago base of ₹4,395.78 Cr, while the Insurance Service Result (the Ind AS 117 analogue of underwriting profit) nearly doubled YoY to ₹383.09 Cr from ₹196.04 Cr. Our pre-result preview, anchored to analyst consensus that had just upgraded FY27 EPS to ₹21.86 after Q1's ₹550 Cr PAT beat, had flagged a ₹540-570 Cr PAT band for this quarter; the actual ₹264.81 Cr lands roughly 51-53% below that range — a clear miss, and a sharp reversal from Q1 FY27's ₹549.74 Cr (down 51.84% QoQ).

The miss does not trace to underwriting. The Combined Operating Ratio improved to 91.97% from 94.52% a year ago and 91.67% in Q1 — comfortably inside, in fact better than, management's own 96-98% target band — and the Insurance Service Margin rose to 8.03% from 5.48% YoY. The shortfall instead sits in investment income: Net Finance Result (chiefly investment income on the policyholder/shareholder book) fell 58.4% sequentially to ₹267.57 Cr from ₹643.69 Cr in Q1 FY27, consistent with mark-to-market swings on the ₹22,490 Cr investment book now carried at fair value under Ind AS 109. A ₹163.63 Cr deferred-tax credit this quarter (versus a ₹5.43 Cr charge a year ago) pulled the effective tax rate down to 24.7% from 28.7%, flattering the YoY PAT comparison somewhat — profit before tax was up a more moderate, though still strong, 215% YoY.

The stock went into the print at ₹546.75, down 0.7% over the past month of trading.

For context: this is the highest quarterly PAT in the last 5 quarters on our records; revenue is at a 5-quarter high.

YoY, on an Ind AS-restated like-for-like basis, PAT is up 232.81% from ₹79.58 Cr (vs. +382% against the previously-reported GAAP ₹54.90 Cr) — comparability is affected by the FY27 Ind AS 117/109 transition

Against the August 2026 concall guidance, the quarter is a mixed scorecard: insurance revenue growth of 15.42% YoY landed inside the guided 15-16% range, and the reinsurance cost ratio fell to 0.48% of revenue, inside the targeted 0.5-0.6% band — both met. Return on Equity, however, was just 2.57% for the quarter (un-annualized; ~8.14% for H1), trailing the "mid-to-high teens, steady-state" aim management laid out, pulled down by the same soft investment quarter. Premium growth also missed the pre-result bar: H1 FY27 Gross Written Premium of ₹9,562.09 Cr (+19.09% YoY) falls well short of the ₹12,500-13,000 Cr H1 figure our preview had flagged, leaving the full-year run-rate short of pace toward the ₹24,000 Cr GWP target unless H2 steps up materially. On governance, the board also approved reclassifying Sthitapragna Advisors LLP from Promoter Group to Public category — the latest turn in a reclassification saga that saw an earlier application withdrawn on September 16, continuing the promoter-structure churn flagged as a pre-result watch item. No standalone management press release accompanied this filing with direct commentary on the quarter.